Amarantus Bioscience Holdings Inc (AMBS)

[JJAAMMAANN]

So, does the recent buy back of old warrants, and the new $20M LPF Deal cover the $1M necessary to pay off the Milestone payment to Memory once the Phase II study is released?

Is this what GC has been waiting on for the funding? Hmmmmm?

CLIA Work was supposed to start 3Q-2013...should be about finished if that is the case...Time to start making money!

Amarantus paid Memory Dx 2.0 million shares of common stock, and will pay a royalty equal to 9% of the net proceeds of all sales resulting from the license. Amarantus will fund the validation study for LymPro, and as has agreed to pay $50,000 to prepare the laboratory for the necessary CLIA work, which we expect to begin in the third quarter of 2013. Memory Dx LLC is entitled to a $1.0 million milestone payment (in cash or stock) upon the successful completion of the phase II validation study, facilitating commercial sale of the product as an "aid to the diagnosis of Alzheimer's disease."

In my Opinion Of Course...